ReviewESMO open2022
Recurrent or primary metastatic cervical cancer: current and future treatments.
C Gennigens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewESMO open2022
C Gennigens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.